TrialClinical and experimental immunology2014
Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial.
A Malbrán et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this paperpooled itcites it